National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 17435-17436 [2017-07185]

Download as PDF 17435 Federal Register / Vol. 82, No. 68 / Tuesday, April 11, 2017 / Notices Number of respondents Form name Number of responses per respondent Total responses Average burden per response (in hours) Total burden hours NURSE Corps LRP Application * ......................................... Authorization to Release Employment Information Form .... 5,500 5,500 1 1 5,500 5,500 2.0 .10 11,000 550 Total .............................................................................. 5,500 ........................ 11,000 ........................ 11,550 * The burden hours associated with this instrument account for both new and continuation applications. Additional (uploaded) supporting documentation is included as part of this instrument and reflected in the burden hours. The estimates of reporting burden for participants are as follows: Number of respondents Form name Number of responses per respondent Total responses Average burden per response (in hours) Total burden hours Participant Semi-Annual Employment Verification Form ..... Total .............................................................................. 2,300 2,300 2 ........................ 4,600 4,600 .5 ........................ 2,300 2,300 Total for Applicants and Participants .................... 7,800 ........................ 15,600 ........................ 13,850 Jason E. Bennett, Director, Division of the Executive Secretariat. [FR Doc. 2017–07273 Filed 4–10–17; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES srobinson on DSK5SPTVN1PROD with NOTICES National Committee on Vital and Health Statistics: Meeting Pursuant to the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) announces the following advisory committee meeting. Name: National Committee on Vital and Health Statistics (NCVHS), Standards Subcommittee Meeting. Date and Times: Wednesday, May 3, 2017: 9:00 a.m.–5:30 p.m. (EDT). Place: U.S. Department of Health and Human Services, Hubert H. Humphrey Building, 200 Independence Avenue, SW., Room 800, Washington, DC 20201, (202) 690–7100. Status: Open. There will be an open comment period during the final 15 minutes of the Subcommittee meeting. Purpose: Health Insurance Portability and Accountability Act (HIPAA) legislation from 1996, as amended, directed the Secretary of HHS to publish regulations implementing a unique health plan identifier (HPID) for health plans (covered entities under the law). In September 2012, HHS published a final rule requiring health plans to obtain a health plan identifier by November 2014. The regulation also permitted other entities to obtain an identifier on a voluntary basis. Any entity that VerDate Sep<11>2014 20:18 Apr 10, 2017 Jkt 241001 obtained an identifier was to begin using it in HIPAA transactions by November 2015. Small health plans would begin using the identifier by November 2016. In February and June of 2014, NCVHS held meetings on the HPID final rule. Following both hearings, NCVHS sent letters to the HHS Secretary stating that the industry was confused about the HPID policy, terminology and the affected entities, and that reporting the HPID in health care transactions provided little benefit or value to the health care system. In October 2014, HHS announced an enforcement discretion period for the HPID rule, halting its implementation. The purpose of this NCVHS Standards Subcommittee meeting is to seek further input from the health care industry for disposition and next steps of the HPID. The times and topics are subject to change. Please refer to the posted agenda for any updates. Contact Persons for More Information: Substantive program information may be obtained from Rebecca Hines, MHS, Executive Secretary, NCVHS, National Center for Health Statistics, Centers for Disease Control and Prevention, 3311 Toledo Road, Hyattsville, Maryland 20782, telephone (301) 458–4715. Information pertaining to meeting content may be obtained from Lorraine Doo, MSW, MPH, or Geanelle G. Herring, MSW, Centers for Medicare & Medicaid Services, Office of Information Technology, Division of National Standards, 7500 Security Boulevard, Baltimore, Maryland 21244, telephone (410) 786–4160. Summaries of meetings and a roster of Committee members are PO 00000 Frm 00029 Fmt 4703 Sfmt 4703 available on the home page of the NCVHS Web site: https:// www.ncvhs.hhs.gov/, where further information including an agenda and instructions to access the audio broadcast of the meetings will also be posted. Should you require reasonable accommodation, please contact the CDC Office of Equal Employment Opportunity on (770) 488–3210 as soon as possible. Date: April 4, 2017. Laina Bush, Deputy Assistant Secretary for Planning and Evaluation, Office of the Assistant Secretary for Planning and Evaluation. [FR Doc. 2017–07194 Filed 4–10–17; 8:45 am] BILLING CODE 4151–05–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract E:\FR\FM\11APN1.SGM 11APN1 17436 Federal Register / Vol. 82, No. 68 / Tuesday, April 11, 2017 / Notices proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; NIAID Peer Review Meeting Date: April 19, 2017. Time: 11:00 a.m. to 2:00 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, 5601 Fishers Lane, Rockville, MD 20892, (Telephone Conference Call). Contact Person: Dharmendar Rathore, Ph.D., Senior Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, Room 3G30, National Institutes of Health/NIAID, 5601 Fishers Lane, Drive, MSC 9823, Bethesda, MD 20892–9823, 240–669–5058, rathored@ mail.nih.gov. The meeting had to be convened at a short notice to evaluate the revised contract proposals received in response to the Nonhuman Primate Core Cellular Immunology Laboratory for AIDS Vaccine Research and Development RFP. Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: April 5, 2017. Natasha M. Copeland, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2017–07185 Filed 4–10–17; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health srobinson on DSK5SPTVN1PROD with NOTICES National Institute of General Medical Sciences; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: NIGMS Initial Review Group; Training and Workforce Development Subcommittee—A Review of T32 Applications. Date: June 15–16, 2017. Time: 8:00 a.m. to 5:00 p.m. VerDate Sep<11>2014 20:18 Apr 10, 2017 Jkt 241001 Agenda: To review and evaluate grant applications. Place: Cambria Suites Rockville, 1 Helen Heneghan Way, Rockville, MD 20850. Contact Person: John J. Laffan, Ph.D., Scientific Review Officer, Office of Scientific Review, National Institute of General Medical Sciences, National Institutes of Health, Natcher Building, Room 3AN18J, Bethesda, MD 20892, 301–594–2773, laffanjo@ mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.375, Minority Biomedical Research Support; 93.821, Cell Biology and Biophysics Research; 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.862, Genetics and Developmental Biology Research; 93.88, Minority Access to Research Careers; 93.96, Special Minority Initiatives; 93.859, Biomedical Research and Research Training, National Institutes of Health, HHS) Dated: April 6, 2017. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2017–07261 Filed 4–10–17; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Aging; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the National Institute on Aging Special Emphasis Panel, May 1, 2017, 1:00 p.m. to May 1, 2017, 4:30 p.m., National Institute on Aging, Gateway Building, 7201 Wisconsin Ave, Suite 2W200C, Bethesda, MD, 20892 which was published in the Federal Register on March 31, 2017, 82 FR 16052. The meeting notice is amended to change the meeting time from 1:00 p.m.–4:30 p.m. to 10:00 a.m.–1:00 p.m. The meeting is closed to the public. Dated: April 6, 2017. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2017–07258 Filed 4–10–17; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of General Medical Sciences Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is PO 00000 Frm 00030 Fmt 4703 Sfmt 4703 hereby given of a meeting of the National Advisory General Medical Sciences Council. The meeting will be open to the public as indicated below, with a short public comment period at the end. Attendance is limited by the space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The open session will also be videocast and can be accessed from the NIH Videocasting and Podcasting Web site (https:// videocast.nih.gov). The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Advisory General Medical Sciences Council. Date: May 25–26, 2017. Closed: May 25, 2017, 8:30 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Natcher Building, Conference Rooms E1 & E2, 45 Center Drive, Bethesda, MD 20892. Open: May 26, 2017, 8:30 a.m. to 12:00 p.m. Agenda: For the discussion of program policies and issues; opening remarks; report of the Director, NIGMS; and other business of the Council. Place: National Institutes of Health, Natcher Building, Conference Rooms E1 & E2, 45 Center Drive, Bethesda, MD 20892. Contact Person: Ann A. Hagan, Ph.D., Associate Director for Extramural Activities, NIGMS, NIH, DHHS, 45 Center Drive, Room 2AN24H, MSC6200, Bethesda, MD 20892– 6200, (301) 594–4499, hagana@ nigms.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. E:\FR\FM\11APN1.SGM 11APN1

Agencies

[Federal Register Volume 82, Number 68 (Tuesday, April 11, 2017)]
[Notices]
[Pages 17435-17436]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-07185]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract

[[Page 17436]]

proposals, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; NIAID Peer Review Meeting
    Date: April 19, 2017.
    Time: 11:00 a.m. to 2:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 5601 Fishers Lane, 
Rockville, MD 20892, (Telephone Conference Call).
    Contact Person: Dharmendar Rathore, Ph.D., Senior Scientific 
Review Officer, Scientific Review Program, Division of Extramural 
Activities, Room 3G30, National Institutes of Health/NIAID, 5601 
Fishers Lane, Drive, MSC 9823, Bethesda, MD 20892-9823, 240-669-
5058, rathored@mail.nih.gov.

    The meeting had to be convened at a short notice to evaluate the 
revised contract proposals received in response to the Nonhuman 
Primate Core Cellular Immunology Laboratory for AIDS Vaccine 
Research and Development RFP.

Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: April 5, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-07185 Filed 4-10-17; 8:45 am]
 BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.